Archimed
 
 
 
  • About Us
  • Fund
  • Support
  • Return
  • Our Companies
  • left
    • About Us
    • Our Companies
    • Sustainability & Impact
  • Fund
    • Our Investment Strategy
    • Our Investors
    • Our Funds
  • Support
    • Our Value Creation Approach
    • Our Team and Network
  • Return
    • Return to Investors
    • Return to People
    • Return to Society
  • right
    • News
    • JOIN OUR TEAM
    • Investor Portal
    • Contact

NEWS

Our Latest News

ARCHIMED buys Cellese, a pioneering developer of growth factors and exosome-based skincare products

ARCHIMED buys Cellese, a pioneering developer of growth factors and exosome-based skincare products

ARCHIMED’s portfolio company DIESSE is developing a blood test for COVID-19 detection – it will be one of the first in the world capable of accurately mapping the spread of the virus

 March

 23, 

2020

ARCHIMED’s DHG completes its first non-UK acquisition, buying Sweden’s GATE Rehab Development AB

 March

 3, 

2020

ARCHIMED acquires Direct Healthcare Group (DHG) from NorthEdge

 December

 12, 

2019

ARCHIMED appoints three new operating and strategic partners

 November

 19, 

2019

Flash News – Bomi Group launches its 2019-2020 Welfare Plan

 November

 19, 

2019

Provepharm Life Solutions lauréate du prix Galien MedStartUp 2018

 November

 19, 

2019

< 1 … 8 9 10 11 12 … 15 >
368
  • ARCHIMED © 2025
  • Our Eco-Design Approach
  • Legal Notice
  • SFDR Disclosures
  • Contact Us
  • LinkedIn
  • Manage your cookies
  • .
    Go top

    Back to top